FeesSafety
Pluang+

BCB Bancorp reports $132.5M Q3 loss amid loan sales and capital raise to strengthen balance sheet

Company Fundamentals
29 Oct 2026, 14:30 WIB
GlobeNewsWire
View Source
Bearish
BCB Bancorp reports $132.5M Q3 loss amid loan sales and capital raise to strengthen balance sheet

BCB Bancorp posted a $132.5 million net loss in Q3 2026, driven by a $115 million provision for credit losses and a $59.9 million tax valuation allowance. The bank raised $98 million in equity capital and sold $204.3 million in problem loans to reduce credit risk and improve its balance sheet. Despite the loss, capital ratios remain solid, and management is focused on risk management and returning to profitability. The company also reorganized its leadership to better align with strategic priorities.

BCB Bancorp's Q3 2026 results provide context for financial sector performance. For readers following financial stocks, here is Pluang's market snapshot as of Oct 29, 2026 17:53 WIB: Of 142 priced Financials-sector US stocks, 94 rose and 43 fell today. ING traded at USD 31.77 with a 3.41% decline and 100% sell orders, contrasting with HUT at USD 67.11, down 3.38% but with 41% buy orders, while MARA fell 3.40% to USD 7.10 with a shorter typical hold time of 24 days.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App